Evaluation of Transcutaneous Electrical Stimulation in Post Stroke Dysphagia

NCT ID: NCT01971320

Last Updated: 2016-08-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE3

Total Enrollment

2 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-06-30

Study Completion Date

2016-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Oropharyngeal dysphagia induces aspirations which could be responsible of aspiration pneumonia and denutrition. It could be present in the majority of central neurological disease (degenerative or vascular disease), which explains that it is the first case of mortality in stroke. Two pilot studies realised by our research group aimed to demonstrate that sensitive transcutaneous electrical stimulation could improve swallowing coordination and reduce aspirations. This technique could be used at home.

The aim of this study is to demonstrate that sensitive electrical stimulation could improve oropharyngeal dysphagia in hemispheric stroke patients. 118 patients should be included in seven centers. Sensitive electrical stimulation will be applied either as active stimulation, either as a placebo. Active electrical stimulation will be realised at 80 hz during 30 minutes, under motor threshold and above sensitive threshold. It will be administrated via surface electrodes over the hyoid bone. Patients will be separated by randomisation.

Patients will be evaluated before and after 6 weeks of use. Methods will evaluation questionnaire, clinical examination and videofluoroscopy. The time of use will also be collected.

We wish to demonstrate that transcutaneous electrical stimulation is able to improve oropharyngeal dysphagia in stroke.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Oropharyngeal Dysphagia Deglutition Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

active stimulation

sensitive electrical stimulation applied during meals with Urostim I for 6 weeks

Urostim I stimulation will be done during meals for 6 weeks

Group Type EXPERIMENTAL

Urostim I stimulation

Intervention Type DEVICE

Urostim I stimulation will be done during meals for 6 weeks

fake stimulation

Urostim I stimulation will be done during meals for 6 weeks

Fake sensitive electrical stimulation applied during meals with modified Urostim I who not deliver stimulation for 6 weeks

Group Type PLACEBO_COMPARATOR

Urostim I stimulation

Intervention Type DEVICE

Urostim I stimulation will be done during meals for 6 weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Urostim I stimulation

Urostim I stimulation will be done during meals for 6 weeks

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age between 18 and 85 years
* No contraindication to electrical stimulation
* Oropharyngeal dysphagia from 8 weeks diagnosed by videofluorosocpy with penetration aspiration scale \> 3 or a residue ≥ 50%
* Due to an hemispheric stroke
* Patients able to understand the videofluroscopy and questionnaires
* For women in age of procreation, to have a contraception, a pregnacy test will be done if not
* Able to swallow (a nasogastric tube is not a contraindication to participate)

Exclusion Criteria

* Pregnancy or breast feeding
* Psychiatric illnes
* Swallowing disorders before the stroke
* Contraindication to electrical stimulation
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Rouen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Eric VERIN, Professor

Role: PRINCIPAL_INVESTIGATOR

UH Rouen

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre les Herbiers

Bois-Guillaume, , France

Site Status

UH Bordeaux

Bordeaux, , France

Site Status

UH Limoges

Limoges, , France

Site Status

AP-HP Fernand WIDAL

Paris, , France

Site Status

UH Rouen

Rouen, , France

Site Status

UH Toulouse

Toulouse, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2013/002/HP

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.